Gennari L, Mazzaferro V, Regalia E, Colella G, Doci R, Bozzetti F, Ammatuna M, Andreola S, Montalto F, Manzi R
Department of Surgery, Istituto Nazionale Tumori, Milan, Italy.
J Surg Oncol Suppl. 1993;3:83-6. doi: 10.1002/jso.2930530523.
Several retrospective analyses have recently shown the advantage of liver transplantation (OLT) for patients with hepatocellular carcinoma (HCC) at early tumor stages. Preliminary results of a prospective series of OLT for unresectable small HCC arising in cirrhosis are reported. Eighteen out of 22 patients (82%) are alive without evidence of HCC recurrence after a median follow-up of 11 months.